| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
|
|
|
|
22 |
11 |
p. 1626-1647
|
artikel
|
| 2 |
Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic
|
Nichols, Russell M
|
|
|
22 |
11 |
p. 1531
|
artikel
|
| 3 |
Correction to Lancet Infect Dis 2022; 22: 1365–73
|
|
|
|
22 |
11 |
p. e310
|
artikel
|
| 4 |
Correction to Lancet Infect Dis 2022; 22: 1329–42
|
|
|
|
22 |
11 |
p. e310
|
artikel
|
| 5 |
Correction to Lancet Infect Dis 2022; published online Aug 31. https://doi.org/10.1016/S1473-3099(22)00434-0
|
|
|
|
22 |
11 |
p. e310
|
artikel
|
| 6 |
Correction to Lancet Infect Dis 2022; published online Sept 22. https://doi.org/10.1016/S1473-3099(22)00590-4
|
|
|
|
22 |
11 |
p. e310
|
artikel
|
| 7 |
Doxycycline PEP for prevention of STIs
|
Venkatesan, Priya
|
|
|
22 |
11 |
p. 1545
|
artikel
|
| 8 |
Ebola returns: back to square one
|
The Lancet Infectious Diseases,
|
|
|
22 |
11 |
p. 1513
|
artikel
|
| 9 |
Emphysematous gastritis due to hypervirulent Klebsiella pneumoniae
|
Saeki, Naomi
|
|
|
22 |
11 |
p. 1648
|
artikel
|
| 10 |
Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil: a spatiotemporal modelling study
|
Ribeiro dos Santos, Gabriel
|
|
|
22 |
11 |
p. 1587-1595
|
artikel
|
| 11 |
Eugene Gangarosa
|
Bagcchi, Sanjeet
|
|
|
22 |
11 |
p. 1549
|
artikel
|
| 12 |
Externalities modulate the effectiveness of the Wolbachia release programme
|
Ooi, Eng Eong
|
|
|
22 |
11 |
p. 1518-1519
|
artikel
|
| 13 |
Full-dose NSAIDs at the first sign of respiratory infection?
|
Donzelli, Alberto
|
|
|
22 |
11 |
p. 1533-1534
|
artikel
|
| 14 |
Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply
|
Ruggenenti, Piero
|
|
|
22 |
11 |
p. 1534
|
artikel
|
| 15 |
Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
|
Jian, Fanchong
|
|
|
22 |
11 |
p. 1535-1537
|
artikel
|
| 16 |
Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial
|
Velasquez-Portocarrero, Daniel E
|
|
|
22 |
11 |
p. 1606-1616
|
artikel
|
| 17 |
How can patients with Clostridioides difficile infection on concomitant antibiotic treatment be best managed?
|
Fitzpatrick, Fidelma
|
|
|
22 |
11 |
p. e336-e340
|
artikel
|
| 18 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
22 |
11 |
p. 1547
|
artikel
|
| 19 |
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
|
Gandasegui, Javier
|
|
|
22 |
11 |
p. e341-e347
|
artikel
|
| 20 |
Learning from the bone allograft tuberculosis outbreak in the USA
|
Hill, Celeste
|
|
|
22 |
11 |
p. 1522-1523
|
artikel
|
| 21 |
Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
|
Arora, Prerna
|
|
|
22 |
11 |
p. 1537-1538
|
artikel
|
| 22 |
Makeda Semret—connecting two worlds in AMR
|
Kirby, Tony
|
|
|
22 |
11 |
p. 1550
|
artikel
|
| 23 |
Monkeypox in pregnancy: update on current outbreak
|
Khalil, Asma
|
|
|
22 |
11 |
p. 1534-1535
|
artikel
|
| 24 |
Monkeypox outbreak in a piercing and tattoo establishment in Spain
|
del Río García, Valme
|
|
|
22 |
11 |
p. 1526-1528
|
artikel
|
| 25 |
Monoclonal antibodies for reducing malaria transmission
|
Daubenberger, Claudia A
|
|
|
22 |
11 |
p. 1519-1520
|
artikel
|
| 26 |
Monoclonal antibody therapies against SARS-CoV-2
|
Focosi, Daniele
|
|
|
22 |
11 |
p. e311-e326
|
artikel
|
| 27 |
Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report
|
Schwartz, Noah G
|
|
|
22 |
11 |
p. 1617-1625
|
artikel
|
| 28 |
New ways of evaluating and purchasing antimicrobials
|
Adler, Amanda
|
|
|
22 |
11 |
p. 1542
|
artikel
|
| 29 |
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
|
Sheward, Daniel J
|
|
|
22 |
11 |
p. 1538-1540
|
artikel
|
| 30 |
Protein-based vaccine as the booster dose for adults: evidence and beyond
|
Shang, Lianhan
|
|
|
22 |
11 |
p. 1515-1517
|
artikel
|
| 31 |
Reconsidering the incubation period of Marburg virus disease
|
Schneider, Kristan A
|
|
|
22 |
11 |
p. 1525-1526
|
artikel
|
| 32 |
Reducing tuberculosis in African children
|
Bagcchi, Sanjeet
|
|
|
22 |
11 |
p. 1544
|
artikel
|
| 33 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
11 |
p. 1548
|
artikel
|
| 34 |
Review of 2022 WHO guidelines on the control and elimination of schistosomiasis
|
Lo, Nathan C
|
|
|
22 |
11 |
p. e327-e335
|
artikel
|
| 35 |
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
|
Mallory, Raburn M
|
|
|
22 |
11 |
p. 1565-1576
|
artikel
|
| 36 |
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study
|
Sadarangani, Manish
|
|
|
22 |
11 |
p. 1553-1564
|
artikel
|
| 37 |
Safety of mRNA COVID-19 vaccines during pregnancy
|
Ellington, Sascha
|
|
|
22 |
11 |
p. 1514-1515
|
artikel
|
| 38 |
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults
|
van der Boor, Saskia C
|
|
|
22 |
11 |
p. 1596-1605
|
artikel
|
| 39 |
13th annual Neglected Tropical Disease NNN conference
|
Jesudason, Timothy
|
|
|
22 |
11 |
p. 1543
|
artikel
|
| 40 |
The considerable complexities of rotavirus vaccination
|
Keddy, Karen H
|
|
|
22 |
11 |
p. 1520-1522
|
artikel
|
| 41 |
The replenishment of the Global Fund
|
Burki, Talha
|
|
|
22 |
11 |
p. 1546-1547
|
artikel
|
| 42 |
The unreachable consensus
|
De Ambrogi, Marco
|
|
|
22 |
11 |
p. 1551
|
artikel
|
| 43 |
The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy
|
Sharland, Mike
|
|
|
22 |
11 |
p. 1528-1530
|
artikel
|
| 44 |
Trends in the global burden of lower respiratory infections: the knowns and the unknowns
|
Li, You
|
|
|
22 |
11 |
p. 1523-1525
|
artikel
|
| 45 |
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study
|
Florentino, Pilar T V
|
|
|
22 |
11 |
p. 1577-1586
|
artikel
|
| 46 |
Viral replication and infectivity of monkeypox through semen
|
Reda, Abdullah
|
|
|
22 |
11 |
p. 1531-1532
|
artikel
|
| 47 |
Viral replication and infectivity of monkeypox through semen – Authors' reply
|
Lapa, Daniele
|
|
|
22 |
11 |
p. 1532-1533
|
artikel
|
| 48 |
What can we learn from the lesser told histories of HIV/AIDS?
|
Ramgolam, Aimee
|
|
|
22 |
11 |
p. 1552
|
artikel
|
| 49 |
WHO Pathogen X conference
|
Skyle, Daniel
|
|
|
22 |
11 |
p. 1541
|
artikel
|
Tijdschrift beschrijving